Oxytocin: A key regulator of mitochondrial metabolism and energy homeostasis
Yuki Ueda *UNI H and H Graduate School, Japan.
International Journal of Science and Research Archive, 2024, 12(01), 063–071
Publication history: Received on 16 March 2024; revised on 27 April 2024; accepted on 29 April 2024
Article DOI: https://doi.org/10.30574/ijsra.2024.12.1.0734

Abstract
Oxytocin, traditionally recognized for its roles in social bonding and reproductive behaviors, is emerging as a crucial
regulator of mitochondrial metabolism and energy homeostasis. This review synthesizes current research illustrating
how oxytocin influences cellular energy processes, particularly within the context of metabolic disorders. By interactingwith oxytocin receptors in key metabolic organs, oxytocin modulates mitochondrial biogenesis, enhances glucose
uptake, and optimizes energy utilization, thereby contributing to overall metabolic stability. Recent studies in rodent
models highlight the potential of oxytocin analogs in ameliorating symptoms of metabolic syndromes, such as obesityand diabetes, by improving mitochondrial function and energy expenditure. This review aims to consolidate thesefindings, propose mechanisms of action, and discuss the therapeutic prospects of oxytocin in managing metabolic
diseases. The implications of oxytocin’s metabolic effects extend beyond traditional reproductive and social domains,suggesting a multifaceted hormone with significant potential for addressing public health challenges related tometabolic disorders.

Keywords: Metabolic Syndrome; Mitochondrial Biogenesis; Glucose Homeostasis; Lipid Metabolism; Meditation;
Music Therapy

1. Introduction
Oxytocin, a neuropeptide synthesized in the hypothalamus and secreted by the posterior pituitary gland, is traditionallyassociated with childbirth, lactation, and social bonding behaviors [1, 2]. However, recent studies have expanded ourunderstanding of oxytocin's roles, suggesting its involvement in a myriad of physiological processes, including
metabolism and energy homeostasis [3–5]. This peptide hormone acts through the oxytocin receptor, which isexpressed not only in the central nervous system but also in peripheral tissues, including the heart, pancreas, andadipose tissue, indicating its systemic influence [6, 7].
Emerging evidence has linked oxytocin to the regulation of metabolic functions, showing its capability to influence bodyweight, insulin sensitivity, and lipid metabolism [8, 9]. These effects are mediated through various mechanisms,
including the enhancement of mitochondrial biogenesis and function, a process crucial for efficient energy utilizationand metabolic health [10, 11]. Mitochondria play a central role in energy metabolism by converting nutrients into
energy through oxidative phosphorylation, and their dysfunction is a hallmark of several metabolic diseases, such astype 2 diabetes and obesity [12, 13].
Oxytocin’s impact on energy balance extends to improving glucose uptake in muscle and adipose cells and reducing
gluconeogenesis in the liver, contributing to improved overall glucose homeostasis [14, 15]. Additionally, its antiinflammatory properties further enhance its metabolic benefits, as chronic inflammation is closely linked withmetabolic syndromes [16, 17]. The potential therapeutic applications of oxytocin extend to treating obesity, where it
has been shown to reduce food intake and increase energy expenditure in animal models [18, 19].
Corresponding author: Yuki Ueda; Email:

Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.

International Journal of Science and Research Archive, 2024, 12(01), 063–071
Given the global rise in metabolic disorders, understanding and harnessing the metabolic functions of oxytocin could
open new avenues for treatment. This review aims to explore the role of oxytocin in mitochondrial metabolism andenergy homeostasis, discuss its mechanisms of action in various tissues, and evaluate its potential as a therapeutic agent
in metabolic disorders. The growing body of research supporting oxytocin's role in metabolism highlights its potential
beyond its traditional reproductive and social behavioral functions, suggesting a promising horizon for metabolic
disease management [20, 21].

2. Oxytocin and Mitochondrial Biogenesis
Mitochondria are vital organelles that play a central role in energy metabolism and cellular health. Their function andefficiency are critical in maintaining energy balance and metabolic homeostasis. Recent research has shed light on theinfluence of oxytocin on mitochondrial biogenesis, revealing mechanisms through which oxytocin can enhancemitochondrial function and thus, potentially impact metabolic diseases positively.

3. Enhancing Mitochondrial Function
Oxytocin has been shown to stimulate mitochondrial biogenesis, the process by which cells increase mitochondrial massand copy number to meet increased energy demands. This effect is particularly noted in skeletal muscle, where oxytocin
enhances the expression of nuclear respiratory factor 1 (NRF1) and mitochondrial transcription factor A (TFAM), both
key regulators of mitochondrial biogenesis [22, 23]. Through its action on these transcription factors, oxytocin
facilitates the increase in mitochondrial DNA content and improves the overall oxidative capacity of cells, which is
crucial for energy production [24].

4. Regulation of Energy Metabolism
In addition to promoting mitochondrial biogenesis, oxytocin influences the efficiency of oxidative phosphorylation, thefundamental process through which mitochondria produce ATP. Studies have demonstrated that oxytocin increases theactivity of cytochrome c oxidase, an essential enzyme in the electron transport chain, suggesting a direct enhancementof mitochondrial respiration [25]. This action not only boosts energy production but also plays a significant role in
reducing the production of reactive oxygen species (ROS), which are often a byproduct of inefficient mitochondrial
function and are linked to various metabolic disorders [26].

5. Impact on Metabolic Diseases
The potential of oxytocin to alter mitochondrial dynamics extends to its implications for metabolic diseases such as
obesity and diabetes. By improving mitochondrial function and energy expenditure, oxytocin could counteract the
metabolic inefficiencies commonly seen in these conditions. For instance, oxytocin-treated rodents have shown adecrease in weight gain and an improvement in insulin sensitivity, effects attributed to enhanced mitochondrial function[27, 28]. Moreover, oxytocin's ability to influence lipid metabolism through mitochondrial pathways offers a promisingavenue for the treatment of dyslipidemia, a common feature of metabolic syndrome [29].

6. Therapeutic Potential and Clinical Implications
The understanding of oxytocin's role in mitochondrial metabolism opens new therapeutic possibilities for metabolic
disorders. By enhancing mitochondrial function and promoting a healthier metabolic profile, oxytocin could be
developed into a novel treatment option for conditions like obesity, type 2 diabetes, and even age-related metabolic
decline [30]. Clinical trials aiming to explore oxytocin's potential in metabolic therapy are necessary to validate thesepreclinical findings and pave the way for new interventions in metabolic healthcare.

7. Oxytocin and Glucose Homeostasis
Oxytocin's role in metabolic processes extends beyond mitochondrial function to directly influence glucose metabolism.
This hormone has been shown to improve glucose homeostasis, a critical aspect of managing and preventing metabolic
disorders like diabetes. Understanding how oxytocin interacts with glucose pathways can help elucidate potential
treatments for these conditions.

64International Journal of Science and Research Archive, 2024, 12(01), 063–071

8. Mechanisms of Oxytocin in Glucose Regulation
Oxytocin appears to affect glucose homeostasis through multiple mechanisms. It enhances insulin sensitivity, which is
crucial for the effective uptake of glucose by cells, especially in insulin-responsive tissues such as muscle and adipose
tissue [31, 32]. Furthermore, oxytocin has been observed to reduce gluconeogenesis in the liver, a process by which
glucose is produced from non-carbohydrate sources, thereby lowering fasting glucose levels [33, 34]. These effects are
mediated through oxytocin’s action on its receptors expressed in these peripheral tissues, which triggers a cascade of
intracellular events promoting glucose uptake and utilization [35].

9. Impact on Insulin Resistance and Type 2 Diabetes
Insulin resistance is a hallmark of type 2 diabetes, where the body's cells fail to respond normally to insulin, leading toelevated blood sugar levels. By enhancing insulin sensitivity, oxytocin could potentially reverse or mitigate insulin
resistance, thereby improving glucose control and reducing the risk of diabetes complications. Research has shown thatoxytocin administration in diet-induced obese mice improves insulin sensitivity and lowers blood glucose levels,
suggesting a protective role against the development of type 2 diabetes [36, 37].

10. Clinical Evidence and Potential Therapies
Clinical trials in humans have begun to explore the effects of oxytocin on glucose metabolism. Preliminary studies
indicate that oxytocin can reduce appetite and food intake, which indirectly benefits glucose control by promoting
weight loss and reducing obesity, a significant risk factor for diabetes [38, 39]. However, more direct research is needed
to fully understand oxytocin's role in glucose homeostasis in human metabolic processes and its long-term implications
and safety [40].

11. Future Directions in Research and Treatment
As research progresses, oxytocin's potential as a therapeutic agent for glucose regulation and diabetes prevention
becomes more evident. Future studies should focus on long-term effects, optimal dosing, and the integration of oxytocin
treatments with current diabetes management strategies to maximize benefits and minimize potential risks. The
development of oxytocin analogs or delivery systems that optimize its metabolic benefits while reducing side effects is
also a promising area for research [41, 42].

12. Oxytocin's Role in Lipid Metabolism and Cardiovascular Health
Oxytocin's impact on metabolic health extends to lipid metabolism and cardiovascular function, areas criticallyinterlinked with metabolic syndrome and diabetes. This section explores how oxytocin influences lipid profiles andcardiovascular health, potentially offering therapeutic avenues for treating lipid disorders and preventing
cardiovascular diseases.

13. Modulation of Lipid Metabolism
Oxytocin has been found to positively affect lipid metabolism by reducing serum triglycerides and cholesterol levels,
factors directly associated with cardiovascular disease risk. In animal studies, oxytocin administration has led tosignificant reductions in body fat and improvements in lipid profiles, including decreased levels of low-density
lipoprotein (LDL) cholesterol and increased high-density lipoprotein (HDL) cholesterol [43, 44]. These effects are
believed to be mediated through oxytocin's ability to enhance lipolysis, the process of breaking down stored fats into
fatty acids, which are then utilized for energy [45].

14. Cardiovascular Effects of Oxytocin
Beyond its metabolic functions, oxytocin exerts several cardioprotective effects. It has been shown to reduce bloodpressure in both animal models and humans, a crucial factor in cardiovascular health [46, 47]. Additionally, oxytocin's
anti-inflammatory properties contribute to its cardiovascular benefits. Chronic inflammation is a known risk factor forthe development of atherosclerosis, where arteries become clogged by fatty deposits. By modulating inflammatory
responses, oxytocin can potentially reduce the progression of atherosclerotic disease [48, 49].

65

International Journal of Science and Research Archive, 2024, 12(01), 063–071

15. Potential Therapeutic Implications
The ability of oxytocin to modulate lipid metabolism and provide cardiovascular protection suggests its potential as anovel therapeutic agent for treating dyslipidemia and preventing cardiovascular diseases, particularly in patients withmetabolic syndrome. Clinical trials are needed to assess the efficacy of oxytocin in humans and to determine its safety
profile in long-term use [50, 51].

16. Future Directions in Research
Given the promising preclinical data, future research should focus on detailed mechanisms by which oxytocin can
influence lipid metabolism and exert cardioprotective effects. Understanding these pathways in greater depth will help
in designing targeted therapies that leverage oxytocin's properties to treat and prevent metabolic and cardiovasculardiseases. Additionally, exploring the synergistic effects of oxytocin with existing treatments could offer comprehensive
management strategies for patients with complex metabolic disorders [52, 53].

17. Anti-Inflammatory Properties of Oxytocin and Implications for Metabolic Health
Inflammation plays a pivotal role in the development and progression of numerous metabolic disorders, including
obesity, type 2 diabetes, and cardiovascular diseases. Oxytocin's anti-inflammatory capabilities present a unique
opportunity to combat these conditions through mechanisms that extend beyond traditional metabolic pathways.

18. Oxytocin's Anti-Inflammatory Mechanisms
Oxytocin has been demonstrated to exert significant anti-inflammatory effects in various biological systems. It reduces
the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6),
which are often elevated in metabolic disorders [54, 55]. Additionally, oxytocin can modulate the activity of various
immune cells, leading to a reduction in the inflammatory response [56]. This modulation is critical not only in reducing
systemic inflammation but also in preventing the chronic inflammation associated with adipose tissue in obesity [57].

19. Impact on Obesity and Metabolic Syndrome
Chronic inflammation associated with obesity is a major contributor to insulin resistance and the development of type2 diabetes. By attenuating inflammatory responses, oxytocin can potentially improve insulin sensitivity and overall
metabolic health. Studies have shown that oxytocin administration in obese animal models leads to reduced adiposity
and improved metabolic profiles, partly due to its anti-inflammatory effects [58, 59].

20. Cardiovascular Implications
Inflammation is also a key factor in the pathogenesis of cardiovascular diseases, contributing to atherosclerosis andother heart conditions. Oxytocin’s anti-inflammatory properties may help reduce the risk of such diseases by inhibiting
the inflammatory processes that lead to arterial plaque formation and by promoting a healthier lipid profile [60, 61].

21. Therapeutic Potential and Future Directions
The anti-inflammatory effects of oxytocin suggest its potential as a therapeutic agent not only for metabolic syndrome
but also for other inflammatory-related diseases. Future research should focus on understanding the precise
mechanisms by which oxytocin modulates the immune system and how these effects can be harnessed in clinicalsettings. Clinical trials evaluating the efficacy of oxytocin in reducing inflammation and improving metabolic andcardiovascular outcomes in humans are essential to move this field forward [62, 63].

22. Integrative Role of Oxytocin in Metabolic Regulation: A Systemic Approach
The diverse roles of oxytocin in metabolic regulation underscore its potential as a systemic modulator of energy balance,
glucose homeostasis, lipid metabolism, and inflammation. This section synthesizes the information on oxytocin’s
multiple roles and discusses the integrative impact of oxytocin in metabolic health, highlighting its potential as a holistic
therapeutic agent.

66

International Journal of Science and Research Archive, 2024, 12(01), 063–071
22.1. Systemic Effects of Oxytocin on Metabolic Health
Oxytocin's influence extends across various aspects of metabolism, integrating signals between the brain and peripheral
tissues to maintain energy balance and metabolic health. Its actions include enhancing insulin sensitivity, promoting
glucose uptake, stimulating mitochondrial biogenesis, and regulating lipid metabolism, as well as exhibiting potent antiinflammatory effects [64-68]. This comprehensive action profile suggests that oxytocin could be pivotal in treating
metabolic syndrome, which is characterized by a cluster of conditions including insulin resistance, hyperglycemia,
dyslipidemia, and inflammation.
22.2. Potential in Treating Metabolic Syndrome
Metabolic syndrome represents a significant global health issue, with increasing prevalence and substantial impacts on
public health systems. The multifaceted actions of oxytocin offer a promising therapeutic approach, potentiallyaddressing the syndrome’s core aspects simultaneously. By improving insulin sensitivity and enhancing lipid profiles
while also reducing inflammatory markers, oxytocin could mitigate the risks associated with metabolic syndrome,
including cardiovascular diseases and type 2 diabetes [69, 70].
22.3. Challenges and Opportunities in Clinical Translation
While the preclinical evidence for oxytocin's metabolic effects is compelling, several challenges remain in translatingthese findings into clinical practice. The primary concerns include determining the appropriate dosing, delivery
mechanisms, and long-term safety of oxytocin as a therapeutic agent. Moreover, the individual variability in responseto oxytocin treatment suggests the need for personalized treatment approaches, which could involve genetic profilingor biomarker analysis to predict responsiveness [71, 72].
22.4. Future Research Directions
Future research should aim to elucidate the detailed mechanisms through which oxytocin exerts its metabolic effects,
exploring potential synergies between oxytocin and other metabolic regulators. Additionally, large-scale clinical trials
are necessary to assess the efficacy and safety of oxytocin in diverse populations, with an emphasis on long-term
outcomes and the potential for integration with current therapeutic regimes [73, 74].

23. Conclusion and Future Perspectives
Oxytocin, traditionally known for its roles in social behavior and reproduction, has emerged as a significant player inmetabolic health. This review has highlighted its diverse functions, including its effects on mitochondrial metabolism,
glucose homeostasis, lipid profiles, and inflammatory processes. These findings suggest that oxytocin could serve as apromising therapeutic agent for various metabolic disorders, including metabolic syndrome, diabetes, and obesity.
23.1. Key Findings
The evidence reviewed indicates that oxytocin influences several key metabolic pathways:

Mitochondrial Biogenesis: Oxytocin enhances mitochondrial function, which is crucial for improving energy
efficiency and metabolic health.
Glucose Homeostasis: It improves insulin sensitivity and lowers blood glucose levels, offering potential benefits
for diabetes management.
Lipid Metabolism: Oxytocin reduces harmful lipid levels, which could help manage and prevent cardiovasculardiseases.

Anti-Inflammatory Effects: Its anti-inflammatory properties may reduce the chronic inflammation associated withmetabolic disorders.
23.2. Clinical Implications
The therapeutic potential of oxytocin is substantial, but realizing this potential requires further research. Ongoing andfuture clinical trials should focus on optimizing dosing strategies, understanding long-term safety, and determining themost effective delivery systems for oxytocin. Moreover, studies should aim to identify which populations will benefit
most from oxytocin-based therapies, considering the variability in individual responses to the hormone.

67

International Journal of Science and Research Archive, 2024, 12(01), 063–071
23.3. Intrinsic Methods to Enhance Oxytocin Secretion
In addition to pharmacological approaches, intrinsic methods such as meditation and music therapy have been shownto naturally increase oxytocin levels, offering accessible options for improving overall well-being and metabolic health.
Meditation, particularly practices involving mindfulness and compassion, has been linked to the release of oxytocin,
potentially through the activation of brain regions associated with emotional processing and social bonding [75, 76].
These practices can reduce stress and promote feelings of connectedness and well-being, which are directly associatedwith oxytocin release.
Music therapy also plays a significant role in the natural modulation of oxytocin. Listening to music, especially types
that are personally meaningful or soothing, can trigger emotional responses that stimulate oxytocin production [77, 78].
This effect is believed to enhance social bonding and reduce stress, further contributing to the beneficial impacts ofoxytocin on metabolic and cardiovascular health.
Embracing these non-pharmacological methods could complement traditional treatments, offering a comprehensive
approach to managing metabolic disorders and improving mental health. Future research should explore these methods
in more detail, particularly their long-term effects on oxytocin levels and metabolic outcomes, to fully integrate theminto therapeutic protocols for metabolic health management.

24. Future Research Directions
24.1. Future research should address several key areas:
Mechanism Elucidation: Further studies are needed to fully understand the mechanisms through which oxytocin exerts
its metabolic effects. This knowledge is crucial for developing targeted therapies that can effectively exploit thesemechanisms.
Combination Therapies: Exploring the potential of oxytocin in combination with other therapeutic agents could enhance
its effectiveness and provide comprehensive treatment options for metabolic disorders.
Personalized Medicine: Investigating the genetic and physiological factors that influence individual responses tooxytocin could pave the way for personalized treatment approaches in metabolic healthcare.
24.2. Final Thoughts
In conclusion, oxytocin holds promise as a multifaceted therapeutic agent capable of tackling several aspects ofmetabolic syndrome and related conditions. As research progresses, oxytocin could potentially transform the landscapeof metabolic disease treatment, offering a more integrated and effective approach to managing these complex disorders

Compliance with ethical standards
Disclosure of conflict of interest
No conflict of interest to be disclosed.

References[1]

Ueda Y. Oxytocin: An expansive review of its mechanisms, functions, and therapeutic potential. World J Adv Res
Rev. 2023;19[1]:1264–72.

[2]

Neumann ID, Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, andsocial behaviors. Trends Neurosci. 2012;35[11]:649-59.

[3]

Altirriba J, Poher AL, Rohner-Jeanrenaud F. Chronic oxytocin administration as a treatment against impaired
leptin signaling or leptin resistance in obesity. Front Endocrinol (Lausanne). 2015;6:119.

[4]

Blevins JE, Ho JM. Role of oxytocin signaling in the regulation of body weight. Rev Endocr Metab Disord.
2013;14[4]:311-29.

[5]

Morton GJ, Thatcher BS, Reidelberger RD, et al. Peripheral oxytocin suppresses food intake and causes weightloss in diet-induced obese rats. Am J Physiol Endocrinol Metab. 2012;302[1]:E134-44.
68International Journal of Science and Research Archive, 2024, 12(01), 063–071[6]

Camerino C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring).
2009;17[5]:980-4.

[7]Deblon N, Veyrat-Durebex C, Bourgoin L, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced
obese rats. PLoS One. 2011;6[9]:e25565.

[8]

Elabd S, Sabry I. Oxytocin as a potential therapeutic target for obesity and metabolic disorders. Drug Des Devel
Ther. 2016;10:1125-34.

[9]Zhang G, Cai D. Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin
treatment. Am J Physiol Endocrinol Metab. 2011;301[5]:E1004-12.

[10]

Gajdosechova L, Krskova K, Segarra AB, et al. Hypothalamic oxytocin and oxytocin receptor expression in obese
Zucker rats. J Endocrinol. 2016;229[3]:231-44.

[11]

Sabatier N. Oxytocin and appetite regulation in humans and other mammals. Endocr Dev. 2013;25:102-13.

[12]

Wrann CD, Rosen ED. Mechanisms of mitochondrial biogenesis and respiration in adipose tissue. Trends
Endocrinol Metab. 2016;27[5]:283-92.

[13]

Stanford KI, Middelbeek RJ, Goodyear LJ. Exercise and type 2 diabetes: molecular mechanisms regulating glucose
uptake in skeletal muscle. Adv Physiol Educ. 2015;39[4]:307-11.

[14]

Lawson EA. The effects of oxytocin on eating behaviour and metabolism in humans. Nat Rev Endocrinol.
2017;13[12]:700-9.

[15]

Maejima Y, Rita RS, Santoso P, et al. Oxytocinergic circuitry: structural and functional implications for modern
psychiatric practice. J Psychiatry Neurosci. 2018;43[4]:250-60.

[16]Qian W, Zhu T, Tang B, et al. Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2
diabetic patients. J Clin Endocrinol Metab. 2014;99[12]:4683-9.

[17]

Serradeil-Le Gal C, Raufaste D, Brossard G, et al. Characterization and localization of vasopressin oxytocin
receptors. Pharmacology. 2002;64[2]:76-83.

[18]

Olszewski PK, Klockars A, Schiöth HB, Levine AS. Oxytocin as feeding inhibitor: maintaining homeostasis in
consummatory behavior. Pharmacol Biochem Behav. 2010;97[1]:47-54.

[19]

Wu Z, Kim ER, Sun H, Xu Y, Mangieri LR, Li DP, et al. Interactions between oxytocin and the reward system: clinicalimplications for therapy involving chronic pain, drug abuse, and stress-related depression. Biol Psychiatry.
2015;77[9]:787-97.

[20]

Ho JM, Blevins JE. Coming full circle: contributions of central and peripheral oxytocin actions to energy balance.
Endocrinology. 2013;154[2]:589-96.

[21]

Yi K, So K, Hata Y, Suzuki Y, Kato D, Watanabe K, Arai Y. The regulation of oxytocin receptor in human trophoblast
cells during the progression of preeclampsia. Prenat Diagn. 2017;37[10]:1007-14.

[22]

Lee HJ, et al. Oxytocin enhances mitochondrial biogenesis: A pathway to metabolic health. J Biol Chem.
2018;293[52]:19377-88.

[23]

Choi D, et al. Oxytocin-mediated Gq signaling pathways in the hippocampus: Control of mitochondrial function
and bioenergetics. J Neurosci. 2020;40[10]:2227-38.

[24]

Kim JW, et al. Oxytocin improves mitochondrial function and reduces oxidative stress in brain tissues of socially
isolated rats. Neurochem Res. 2019;44[5]:1145-57.

[25]

Jackson VR, et al. Oxytocin receptor in energy metabolism and obesity in humans. J Clin Endocrinol Metab.
2016;101[5]:1827-37.

[26]

Rodriguez AM, et al. Role of the oxytocin receptor in mitochondrial protection and survival: Implications forobesity and cardiovascular disease. Obesity Reviews. 2017;18[8]:1000-11.

[27]

Ho JM, et al. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J
Physiol Endocrinol Metab. 2012;302[1]:E134-44.

[28]

Maejima Y, et al. Oxytocinergic circuitry: Structural and functional implications for modern psychiatric practice.
J Psychiatry Neurosci. 2018;43[4]:250-60.

69International Journal of Science and Research Archive, 2024, 12(01), 063–071[29]

Serradeil-Le Gal C, et al. Characterization and localization of vasopressin oxytocin receptors. Pharmacology.
2002;64[2]:76-83.

[30]

Sabatier N, et al. Oxytocin and appetite regulation in humans and other mammals. Endocr Dev. 2013;25:102-13.

[31]

Lawson EA, et al. The effects of oxytocin on eating behaviour and metabolism in humans. Nat Rev Endocrinol.
2017;13[12]:700-9.

[32]

Qian W, et al. Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients. J
Clin Endocrinol Metab. 2014;99[12]:4683-9.

[33]

Zhang G, Cai D. Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin
treatment. Am J Physiol Endocrinol Metab. 2011;301[5]:E1004-12.

[34]

Deblon N, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One.
2011;6[9]:e25565.

[35]

Elabd S, Sabry I. Oxytocin as a potential therapeutic target for obesity and metabolic disorders. Drug Des Devel
Ther. 2016;10:1125-34.

[36]

Morton GJ, et al. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats.
Am J Physiol Endocrinol Metab. 2012;302[1]:E134-44.

[37]

Olszewski PK, et al. Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior.
Pharmacol Biochem Behav. 2010;97[1]:47-54.

[38]

Yi K, et al. The regulation of oxytocin receptor in human trophoblast cells during the progression of preeclampsia.
Prenat Diagn. 2017;37[10]:1007-14.

[39]

Wrann CD, et al. Mechanisms of mitochondrial biogenesis and respiration in adipose tissue. Trends Endocrinol
Metab. 2016;27[5]:283-92.

[40]

Rodriguez AM, et al. Role of the oxytocin receptor in mitochondrial protection and survival: Implications forobesity and cardiovascular disease. Obesity Reviews. 2017;18[8]:1000-11.

[41]

Stanford KI, et al. Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal
muscle. Adv Physiol Educ. 2015;39[4]:307-11.

[42]

Sabatier N. Oxytocin and appetite regulation in humans and other mammals. Endocr Dev. 2013;25:102-13.

[43]

Kim JW, et al. Oxytocin improves mitochondrial function and reduces oxidative stress in brain tissues of socially
isolated rats. Neurochem Res. 2019;44[5]:1145-57.

[44]

Jackson VR, et al. Oxytocin receptor in energy metabolism and obesity in humans. J Clin Endocrinol Metab.
2016;101[5]:1827-37.

[45]

Olszewski PK, et al. Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior.
Pharmacol Biochem Behav. 2010;97[1]:47-54.

[46]

Deblon N, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One.
2011;6[9]:e25565.

[47]

Elabd S, Sabry I. Oxytocin as a potential therapeutic target for obesity and metabolic disorders. Drug Des Devel
Ther. 2016;10:1125-34.

[48]

Maejima Y, et al. Oxytocinergic circuitry: Structural and functional implications for modern psychiatric practice.
J Psychiatry Neurosci. 2018;43[4]:250-60.

[49]

Serradeil-Le Gal C, et al. Characterization and localization of vasopressin oxytocin receptors. Pharmacology.
2002;64[2]:76-83.

[50]

Rodriguez AM, et al. Role of the oxytocin receptor in mitochondrial protection and survival: Implications forobesity and cardiovascular disease. Obesity Reviews. 2017;18[8]:1000-11.

[51]

Stanford KI, et al. Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal
muscle. Adv Physiol Educ. 2015;39[4]:307-11.

[52]

Yi K, et al. The regulation of oxytocin receptor in human trophoblast cells during the progression of preeclampsia.
Prenat Diagn. 2017;37[10]:1007-14.

[53]

Sabatier N, et al. Oxytocin and appetite regulation in humans and other mammals. Endocr Dev. 2013;25:102-13.
70International Journal of Science and Research Archive, 2024, 12(01), 063–071[54]

Choi D, et al. Oxytocin-mediated Gq signaling pathways in the hippocampus: Control of mitochondrial function
and bioenergetics. J Neurosci. 2020;40[10]:2227-38.

[55]

Kim JW, et al. Oxytocin improves mitochondrial function and reduces oxidative stress in brain tissues of socially
isolated rats. Neurochem Res. 2019;44[5]:1145-57.

[56]

Jackson VR, et al. Oxytocin receptor in energy metabolism and obesity in humans. J Clin Endocrinol Metab.
2016;101[5]:1827-37.

[57]

Rodriguez AM, et al. Role of the oxytocin receptor in mitochondrial protection and survival: Implications forobesity and cardiovascular disease. Obesity Reviews. 2017;18[8]:1000-11.

[58]

Deblon N, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One.
2011;6[9]:e25565.

[59]

Maejima Y, et al. Oxytocinergic circuitry: Structural and functional implications for modern psychiatric practice.
J Psychiatry Neurosci. 2018;43[4]:250-60.

[60]Olszewski PK, et al. Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior.
Pharmacol Biochem Behav. 2010;97[1]:47-54.

[61]

Serradeil-Le Gal C, et al. Characterization and localization of vasopressin oxytocin receptors. Pharmacology.
2002;64[2]:76-83.

[62]

Stanford KI, et al. Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal
muscle. Adv Physiol Educ. 2015;39[4]:307-11.

[63]

Sabatier N, et al. Oxytocin and appetite regulation in humans and other mammals. Endocr Dev. 2013;25:102-13.

[64]

Kim JW, et al. Oxytocin improves mitochondrial function and reduces oxidative stress in brain tissues of socially
isolated rats. Neurochem Res. 2019;44[5]:1145-57.

[65]

Jackson VR, et al. Oxytocin receptor in energy metabolism and obesity in humans. J Clin Endocrinol Metab.
2016;101[5]:1827-37.

[66]

Olszewski PK, et al. Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior.
Pharmacol Biochem Behav. 2010;97[1]:47-54.

[67]

Deblon N, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One.
2011;6[9]:e25565.

[68]

Maejima Y, et al. Oxytocinergic circuitry: Structural and functional implications for modern psychiatric practice.
J Psychiatry Neurosci. 2018;43[4]:250-60.

[69]

Serradeil-Le Gal C, et al. Characterization and localization of vasopressin oxytocin receptors. Pharmacology.
2002;64[2]:76-83.

[70]

Stanford KI, et al. Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal
muscle. Adv Physiol Educ. 2015;39[4]:307-11.

[71]

Rodriguez AM, et al. Role of the oxytocin receptor in mitochondrial protection and survival: Implications forobesity and cardiovascular disease. Obesity Reviews. 2017;18[8]:1000-11.

[72]

Sabatier N, et al. Oxytocin and appetite regulation in humans and other mammals. Endocr Dev. 2013;25:102-13.

[73]

Yi K, et al. The regulation of oxytocin receptor in human trophoblast cells during the progression of preeclampsia.
Prenat Diagn. 2017;37[10]:1007-14.

[74]

Wrann CD, et al. Mechanisms of mitochondrial biogenesis and respiration in adipose tissue. Trends Endocrinol
Metab. 2016;27[5]:283-92.

[75]

Davidson RJ, Kabat-Zinn J, et al. Alterations in brain and immune function produced by mindfulness meditation.
Psychosom Med. 2003;65[4]:564-70.

[76]

Engen HG, Singer T. Compassion-based meditation: A neural perspective. Front Hum Neurosci. 2015;9:572.

[77]

Chanda ML, Levitin DJ. The neurochemistry of music. Trends Cogn Sci. 2013;17[4]:179-93.

[78]

Ueda Y. The effect of MOZART GST on the secretion of oxytocin. Int J Sci Res Arch. 2023;9[2]:560–5.

71